Advertisement
Research ArticleArticle

Assay Conditions Influence Affinities of Rat Organic Cation Transporter 1: Analysis of Mutagenesis in the Modeled Outward-Facing Cleft by Measuring Effects of Substrates and Inhibitors on Initial Uptake

Valentin Gorboulev, Saba Rehman, Christoph M. Albert, Ursula Roth, Marleen J. Meyer, Mladen V. Tzvetkov, Thomas D. Mueller and Hermann Koepsell
Molecular Pharmacology April 2018, 93 (4) 402-415; DOI: https://doi.org/10.1124/mol.117.110767

Abstract

The effects of mutations in the modeled outward-open cleft of rat organic cation transporter 1 (rOCT1) on affinities of substrates and inhibitors were investigated. Human embryonic kidney 293 cells were stably transfected with rOCT1 or rOCT1 mutants, and uptake of the substrates 1-methyl-4-phenylpyridinium+ (MPP+) and tetraethylammonium+ (TEA+) or inhibition of MPP+ uptake by the nontransported inhibitors tetrabutylammonium+ (TBuA+), tetrapentylammonium+ (TPeA+), and corticosterone was measured. Uptake measurements were performed on confluent cell layers using a 2-minute incubation or in dissociated cells using incubation times of 1, 5, or 10 seconds. With both methods, different apparent Michaelis-Menten constant (Km) values, different IC50 values, and varying effects of mutations were determined. In addition, varying IC50 values for the inhibition of MPP+ uptake and varying effects of mutations were obtained when different MPP+ concentrations far below the apparent Km value were used for uptake measurements. Eleven mutations were investigated by measuring initial uptake in dissociated cells and employing 0.1 µM MPP+ for uptake during inhibition experiments. Altered affinities for substrates and/or inhibitors were observed when Phe160, Trp218, Arg440, Leu447, and Asp475 were mutated. The mutations resulted in changes of apparent Km values for TEA+ and/or MPP+. Mutation of Trp218 and Asp475 led to altered IC50 values for TBuA+, TPeA+, and corticosterone, whereas the mutation of Phe160 and Leu447 changed the IC50 values for two inhibitors. Thereby amino acids in the outward-facing conformation of rOCT1 could be identified that interact with structurally different inhibitors and probably also with different substrates.

Introduction

Organic cation transporters (OCTs) OCT1, OCT2, and OCT3 (SLC22A1-3) of the major facilitator superfamily MFS play pivotal roles in the absorption, excretion, and tissue distribution of many cationic drugs including psychopharmaca and cytostatics (Koepsell et al., 2007; Ahlin et al., 2008; Nies et al., 2011; Koepsell, 2013; Lin et al., 2015; Chen et al., 2017). The polyspecificity of OCTs explains their predominant role for drug bioavailability and the high probability for drug-drug interactions at the transporter level. The identification of drugs that are transported by OCTs or inhibit OCTs has become an important issue in pharmacology. For example, in vitro testing of human OCT1 (hOCT1) for drug-drug interactions was recommended in 2015 by the European Medicines Agency. Although methods to identify new substrates and inhibitors of OCTs have been established, so far no satisfying strategies for in silico and/or in vitro distinction between substrates and inhibitors and for elucidation of biomedically relevant effects of transporter polymorphisms have been found (Koepsell, 2015; Chen et al., 2017). The reasons are that the transport mechanisms of OCTs are not fully understood, no crystal structures are available, and our molecular understanding of cation binding and translocation based on mutagenesis is very limited.

Previously, we investigated the transport mechanisms of OCT1 and OCT2 expressed in oocytes of Xenopus laevis. We provided evidence that these transporters are polyspecific facilitated diffusion systems that can operate as electrogenic uniporters or as electroneutral cation exchangers (Busch et al., 1996b; Arndt et al., 1998; Budiman et al., 2000; Volk et al., 2003; Koepsell, 2011). Studying structure-function relationships in rat OCT1 (rOCT1), we determined the effects of several single point mutations on affinities of substrates and inhibitors (Gorboulev et al., 1999, 2005; Popp et al., 2005; Volk et al., 2009). We interpreted these data with the help of homology models obtained using the crystal structure of bacterial Lac permease transporter, which belongs to the MFS superfamily (Pao et al., 1998; Abramson et al., 2003), as template. To determine the effects of mutations on the affinities of tetraethylammonium+ (TEA+) and 1-methyl-4-phenylpyridinium+ (MPP+) uptake and on uptake inhibition by the nontransported inhibitors corticosterone and tetrabutylammonium+ (TBuA+), rOCT1 mutants expressed in oocytes were characterized by measuring the uptake of radioactive substrates or substrate-induced inward currents. For inhibition studies, we measured the uptake of radioactive substrates using substrate concentrations below the apparent Michaelis-Menten constant (Km) value and a 30-minute incubation time or substrate-induced inward current using substrate concentrations above the apparent Km value and a 45-second incubation time. For molecular interpretations, we made simplifying assumptions (e.g., that the effects of mutations in the modeled outward-open cleft on affinities of the inhibitors indicate inhibitor interactions with the mutated amino acids). We became concerned about whether interpretations that were based on uptake measured after a 30-minute incubation time hold true because these measurements are not supposed to represent a defined transport mode.

During recent years, increasing evidence has been obtained that indicates complex structure-function relationships in OCTs that allow direct and indirect interactions between structurally different substrates and/or inhibitors. Thus, OCTs contain low-affinity and high-affinity binding sites, and cation binding to these sites may lead to direct cation replacement and/or allosteric interactions (Gorbunov et al., 2008; Minuesa et al., 2009; Koepsell, 2011, 2015). Different affinities of inhibitors of hOCT1 and hOCT2 were determined when different substrates were used for the uptake measurement (Ahlin et al., 2011; Belzer et al., 2013; Thévenod et al., 2013). In addition, different affinities for the inhibition of hOCT2 were obtained when 2-minute uptake measurements were performed in confluent cells versus 1-second uptake measurements in dissociated cells (Thévenod et al., 2013).

In the present study, we show that mutations of individual amino acids in rOCT1 may have quite different effects on apparent Km values of MPP+ and TEA+ uptake, and on half-maximal IC50 values of MPP+ uptake when different experimental conditions are used in the uptake measurements. To identify amino acids that interact with the nontransported inhibitors TBuA+, corticosterone, and tetrapentylammonium+ (TPeA+), we analyzed the effects of various mutations of amino acids located in the outward-open cleft of our three-dimensional (3D) homology model on IC50 values of uptake under trans-zero conditions. The measurements were performed in stably transfected, dissociated human embryonic kidney (HEK) 293 cells using a 1-, 5-, or 10-second incubation time and a fixed low MPP+ concentration for uptake in inhibition studies. The obtained data suggest that five amino acids in the outward-open cleft interact with TEA+ and/or MPP+ and indicate that four of these interact with TBuA+, TPeA+, and/or corticosterone.

Materials and Methods

Materials.

[3H]MPP+ (3.1 TBq/mmol) and [14C]TEA+ (1.9 GBq/mmol) were purchased from American Radiolabeled Chemicals (St. Louis, MO). All other chemicals were obtained as described previously (Arndt et al., 2001; Popp et al., 2005; Tzvetkov et al., 2012).

Cloning.

For expression in oocytes and transfection of HEK293 cells, wild-type rOCT1 (Gründemann et al., 1994) and rOCT1 mutants (Popp et al., 2005; Volk et al., 2009) were cloned into various vectors. The single point mutations were generated by polymerase chain reaction applying the overlap extension method (Ho et al., 1989), and all mutations were verified by DNA sequencing. For expression in oocytes, wild-type rOCT1 and rOCT1 mutants were cloned into vector pRSSP (Busch et al., 1996b). For transfection of HEK293 cells, rOCT1 and mutants were cloned into EcoRV/NotI sites of vector pcDNA3.1 (Egenberger et al., 2012) or into EcoRV/HindIII sites of the vector pcDNA5.1 (Tzvetkov et al., 2012).

Expression of rOCT1 and rOCT1 Mutants in Oocytes of X. laevis.

pRSSP plasmids were purified and linearized with MluI. m7G(5′)ppp(5′)G-capped complementary RNAs (cRNAs) were prepared, and the cRNA concentrations were estimated from ethidium bromide–stained agarose gels (Gründemann and Koepsell, 1994). Stage V--VI oocytes of X. laevis were obtained by partial ovariectomy, follicle cells were removed by treatment with collagenase A, and oocytes were stored in Ori buffer (5 mM MOPS, 100 mM NaCl, 3 mM KCl, 2 mM CaCl2, and 1 mM MgCl2 adjusted to pH 7.4 using NaOH) supplemented with 50 mg/l gentamycin. The oocytes were injected with 50 nl of H2O containing 10 ng of cRNA encoding the transporters. For transporter expression, the oocytes were incubated for 3 days at 16°C in Ori buffer containing 50 mg/ml gentamicin.

Measurement of MPP+ Uptake in Oocytes.

Transporter-expressing oocytes or control oocytes without cRNA injection were incubated for 30 minutes at room temperature with Ori buffer containing varying concentrations of TEA+ traced with [14C]TEA+, with varying concentrations of MPP+ traced with [3H]MPP+, or 0.1 µM MPP+ traced with [3H]MPP+ plus varying concentrations of TEA+ or with TBuA+. Oocytes were washed with ice-cold Ori buffer, solubilized with 5% SDS in water, and the radioactivity was analyzed by liquid scintillation counting. Correction for nonspecific uptake was performed by subtracting uptake rates measured in noninjected control oocytes from the same batch of oocytes.

Generation and Cultivation of Stably Transfected HEK Cells.

HEK293 cells were transfected with vector pcDNA5.1 or pcDNA3.1 containing rOCT1 wild-type and rOCT1 mutants and selected for stably transfected cell lines as described previously (Busch et al., 1996a). Cell lines exhibiting the highest saturable MPP+ uptake were used for further studies. The cells were cultivated at 37°C in Dulbecco’s modified Eagle’s medium containing 3.7 g/l NaHCO3, 1.0 g/l d-glucose, 2 mM l-glutamine, 10% heat-inactivated fetal calf serum, 100,000 U/l penicillin, 100 mg/l streptomycin, and 0.8 g/l G418 (Geneticin; Thermo Fisher Scientific). Cultivation was performed in a humidified atmosphere containing 5% CO2.

Two-Minute Uptake Measurements of MPP+ in Monolayers of HEK293 Cells at 37°C.

HEK293 cells, which were stably transfected with vector pcDNA5.1 containing wild-type rOCT1, the rOCT1 mutants Y222F, D475E, or hOCT1 were cultivated in six-well plates until reaching confluence. After washing two times with 137 mM NaC1, 2.7 mM KCl, 8 mM Na2HPO4, and 1.6 mM KH2PO4, pH 7.4 [phosphate-buffered saline (PBS)] supplemented with 0.5 mM MgCl2 and 1 mM CaCl2 (Mg-Ca-PBS) (37°C), the monolayers were incubated for 2 minutes at 37°C with Mg-Ca-PBS containing varying concentrations of MPP+ traced with [3H]MPP+, TEA+ traced with [14C]TEA+, or 0.1 µM MPP+ traced with [3H]MPP+ plus varying concentrations of TEA+, MPP+, or TBuA+. Uptake was stopped by washing with ice-cold PBS, cells were solubilized with 0.2 ml of 4 M guanidine thiocyanate and analyzed for radioactivity.

Measurements of Initial Uptake Rates in Dissociated HEK293 Cells at 37°C.

HEK293 cells stably transfected with vector pcDNA3.1 containing rOCT1 or rOCT1 mutants were cultivated until confluence. The cells were washed twice with PBS and suspended in the same buffer by shaking at room temperature. The cells were collected by centrifugation (10 minutes, 1000g) and suspended (108 cells/ml) at 37°C in Mg-Ca-PBS. Initial uptake rates in HEK293 cells expressing wild-type rOCT1 and most mutants were measured after incubation for 1 second with radioactively traced MPP+ or for 10 seconds with radioactively traced TEA+. In HEK293 cells expressing mutant rOCT1(D475E), which has a largely reduced transport activity compared with wild-type rOCT1 (Gorboulev et al., 1999), MPP+ uptake was measured after 5 seconds of incubation with substrates. To measure the inhibition of MPP+ uptake by TEA+, TBuA+, TPeA+, or corticosterone, the inhibitors were added together with MPP+. Using these incubation times, the measurements are supposed to represent trans-zero substrate uptake, and passive diffusion of TPeA+ and corticosterone was supposed to be negligible. To perform the short-time uptake measurements, 90 µl of HEK293 cell suspension was placed at the bottom of 2-ml tubes and mixed by agitation in a water bath at 37°C. The uptake measurements were performed tube by tube employing a switched-on vortexing device and a metronome providing a 1-s pulse. Ten microliters of Mg-Ca-PBS buffer containing 1 mg/ml albumin and the appropriate concentration of inhibitor and/or radioactive and nonradioactive substrate was placed on the inner wall of the tube about 0.5 cm above the surface of the cell suspension. Albumin was added to increase the adhesion of the radioactive solution to the reaction vessel. Uptake measurement was started by mixing the solutions. For uptake measurements, the tube was added to the vortexer and stopped by the addition of 1 ml of ice-cold stop solution after 1, 5, or 10 seconds, as indicated by the metronome. The stop solution consisted of PBS containing 100 µM quinine. After two centrifugation/washing steps with ice-cold stop solution, cell pellets were solubilized with 0.2 ml of 4 M guanidine thiocyanate. Two milliliters of scintillation liquid was added, and radioactivity was determined by liquid scintillation counting.

Statistics and Fitting Procedures.

For uptake measurements of [3H]MPP+ or [14C]TEA+ into oocytes, at least three different experiments employing different batches of oocytes were used. In each experiment, 8–10 oocytes were analyzed per experimental condition. For the determination of uptake rates of MPP+ or TEA+ into HEK293 cells, at least three different experiments were performed. In each experiment, four individual measurements were performed per experimental condition. The software package GraphPad Prism version 4.1 (GraphPad Software, San Diego, CA) was used to compute statistical parameters. Apparent Km values were determined by fitting the Michaelis-Menten equation (Fig. 1A; Table 1) or the Hill equation (Figs. 2–4; Tables 2 and 3) to substrate activation measurements. The data are presented as the replacement of radioactive substrate by nonlabeled substrate to avoid large scatter at high substrate concentrations. The equations used are indicated in Supplemental Fig. 1. In wild-type rOCT1 and most mutants, the obtained Hill coefficient was not statistically significantly different from one, and similar apparent Km values were determined using the Michaelis-Menten or Hill equation. Attempts to fit the two-site competition model indicated in Supplemental Fig. 1 to the substrate replacement curves did not resolve two sites and did not improve the goodness of the fit. Half-maximal concentration values for the inhibition of [3H]MPP+ transport (IC50) by substrates and nontransported inhibitors were determined by fitting the Hill equation to the data after subtracting uptake that could not be inhibited by the highest concentration of the respective compound that was used (see equation in Supplemental Fig. 1). Fitting the two-site competition model shown in Supplemental Fig. 1 to the inhibition data did not resolve two inhibitory sites. The presented apparent Km values and IC50 values, which were obtained by fitting data from individual experiments, are the mean ± S.D. The curves indicated in Figs. 2–7 were obtained by fitting the Hill equation to data from the compiled experiments. In the graphs presented, individual data points are presented as mean ± S.D. values from three or four individual experiments. When more than two groups were compared, the statistical significance of differences was determined by analysis of variance (ANOVA) using a post hoc Tukey comparison. The Student’s t test was used for the evaluation of statistical significance of difference between two groups. P < 0.05 was considered statistically significant.

Fig. 1.
Fig. 1.

Experimental conditions influence the effects of mutations in rOCT1 on the affinities of substrates and inhibitors. Apparent Km values for TEA+ and MPP+ uptake (A), and IC50 values for the inhibition of MPP+ uptake by TEA+ (B) or by TBuA+ (C) mediated by rOCT1 wild-type and two rOCT1 mutants were determined using different experimental conditions, as described in Table 1. I, Initial uptake of MPP+ or TEA+ was measured in dissociated HEK293 cells (white bars). Incubation times of 1 second (MPP+ uptake by rOCT1 and mutant Y222F), 5 seconds (MPP+ uptake by mutant D475E), or 10 seconds (TEA+ uptake) were used. II, Uptake of MPP+ was measured in monolayers of HEK293 cells using an incubation time of 2 minutes, shown in gray bars. III, Uptake of MPP+ was measured in oocytes using an incubation time of 30 minutes, shown in black bars. The apparent Km values and IC50 values determined for the mutants presented in Table 1 were normalized to the respective mean values determined for rOCT1 wild-type. Mean ± S.D. values of three or more experiments (Table 1) are indicated. *P < 0.05; **P < 0.01; ***P < 0.001, significance of difference determined by ANOVA with post hoc Tukey test; ●P < 0.05; ●●P < 0.01; ●●●P < 0.001, significance of difference determined by Student’s t test.

View this table:
TABLE 1

Comparison of apparent Km values and IC50 values of rOCT1 wild-type and two rOCT1 mutants determined under different experimental conditions

Apparent Km values of TEA+ and MPP+ uptake and IC50 values for the inhibition of uptake of 0.1 µM MPP+ by TEA+ or TBuA+ mediated by rOCT1, rOCT1(Y222F), and rOCT1(D475E) were determined. The measurements were performed with stably transfected HEK293 cells (I, II) or with oocytes in which the transporters were expressed (III). I, Tracer uptake was measured in dissociated HEK293 cells at 37°C after incubation for 1 second [MPP+ uptake in rOCT1 and rOCT1(Y222F)], 5 seconds [MPP+ uptake in rOCT1(D475E)], or 10 seconds (TEA+ uptake). In Figs. 3–5 and Supplemental Fig. 4, the compiled uptake measurements are shown. II, Tracer uptake was measured in monolayers of HEK293 cells at 37°C after incubation for 2 min. The uptake measurements are shown in Supplemental Figs. 2 and 3. III, Tracer uptake was measured in oocytes expressing rOCT1 or rOCT1 mutants after 30-min incubation at room temperature. These data are taken from our previous publications (Gorboulev et al., 1999, 2005; Popp et al., 2005). The apparent Km values were calculated by fitting the Michaelis-Menten equation to the data, whereas IC50 values were calculated by fitting the Hill equation to the data. Values are given as the mean ± S.D. values; the numbers of experiments are indicated in parenthesis.

Fig. 2.
Fig. 2.

Inhibition of MPP+ uptake mediated by wild-type rOCT1, rOCT1(Y222F), or rOCT1(D475E) by TBuA+ measured at three different MPP+ concentrations far below the apparent Km values for MPP+. In HEK293 cells stably transfected with the rOCT1, rOCT1(Y222F) or rOCT1(D475E) initial uptake measurements of 0.25, 12.5, or 100 nM MPP+ in the presence of different concentrations of TBuA+ were performed. Mean ± S.D. values of three independent experiments are indicated. The data were normalized to MPP+ uptake in the absence of TBuA+. The curves were obtained by fitting the Hill equation to the data. Mean ± S.D. values of Hill coefficients are indicated that were determined by fitting the Hill equation to individual experiments. ●P < 0.05 for difference to the Hill coefficient obtained for TBuA+ inhibition measured with 100 nM MPP+ determined by Student’s t test.

Fig. 3.
Fig. 3.

Substrate dependence of initial rates of MPP+ uptake mediated by wild-type rOCT1 and rOCT1 mutants expressed in HEK293 cells. (A) Effects of mutations of Phe160. (B) Effects of mutations of Trp218. (C) Effects of mutations of Tyr222, Thr226, and Arg440. (D) Effects of mutations of Leu447 and Asp475. In stably transfected HEK293 cells, the initial uptake rates of 12.5 nM MPP+ traced with [3H]MPP+ were measured without and with the addition of nonradioactive MPP+. The total concentrations of MPP+ are indicated on the abscissa. Mean ± S.D. values of three or four independent experiments are shown. The data were normalized to uptake of 12.5 nM MPP+. The replacement curves of [3H]MPP+ uptake by nonradioactive MPP+ were obtained by fitting the Hill equation to the data. Mean ± S.D. values of Hill coefficients are indicated that were determined by fitting the Hill equation to individual experiments. ●P < 0.05, for difference to the Hill coefficient of wild-type rOCT1 determined by Student’s t test. ▲Mean value of Hill coefficient is more than 2× the S.D. below 1.

Fig. 4.
Fig. 4.

Substrate dependence of initial rates of TEA+ uptake mediated by wild-type rOCT1 and rOCT1 mutants expressed in HEK293 cells. (A) Effects of mutations of Phe160. (B) Effects of mutations of Trp218. (C) Effects of mutations of Tyr222, Thr226, and Arg440. (D) Effects of mutations of Leu447 and Asp475. In stably transfected HEK293 cells, the initial uptake rates of 1 µM TEA+ traced with [14C]TEA+ were measured in the presence of different concentrations of nonradioactive TEA+. The total concentrations of TEA are indicated on the abscissa. Mean ± S.D. values of three or four independent experiments are shown. The data were normalized to the uptake of 1 µM TEA+. The replacement curves of [14C]TEA+ uptake by nonradioactive TEA+ curves were obtained by fitting the Hill equation to the data. Mean ± S.D. values of Hill coefficients are indicated that were determined by fitting the Hill equation to individual experiments. ●●P < 0.01, for difference to the Hill coefficient of wild-type rOCT1 determined by Student’s t test.

View this table:
TABLE 2

Influence on the substrate concentration used for uptake measurement on affinity of TBuA+ for inhibition of MPP+ uptake mediated by rOCT1 wild-type and two rOCT1 mutants

Initial uptake of different concentrations of MPP+ into HEK293 cells stably transfected with rOCT1, rOCT1(Y222F), or rOCT1(D475E) was measured in the presence of different concentrations of TBuA+, and the IC50 values for TBuA+ inhibition were determined by fitting the Hill equation to data of individual experiments. Mean ± S.D. values of three or four experiments are shown. The compiled uptake measurements and the calculated Hill coefficients are shown in Fig. 2.

View this table:
TABLE 3

Apparent Km values of MPP+ and TEA+ transport mediated by rOCT1 wild-type and rOCT1 mutants

Initial uptake rates of nine different concentrations radioactively traced MPP+ or TEA+ were measured at 37°C in stably transfected HEK293 cells and apparent Km values were determined by fitting the Hill equation to data of individual experiments. Mean values ± S.D. of three or four separate experiments are shown. The compiled uptake measurements and the calculated Hill coefficients are shown in Figs. 3 and 4.

Fig. 5.
Fig. 5.

Inhibition of MPP+ uptake mediated by rOCT1 wild-type or rOCT1 mutants by extracellular TBuA+. (A) Effects of mutations of Phe160. (B) Effects of mutations of Trp218. (C) Effects of mutations of Tyr222, Thr226, and Arg440. (D) Effects of mutations of Leu447 and Asp475. In stably transfected HEK293 cells, initial uptake rates of 0.1 µM MPP+ traced with [3H]MPP+ were measured in the absence and presence of different concentrations of TBuA+. Mean ± S.D. values of three or four independent experiments are indicated. The data were normalized to MPP+ uptake measured in the absence of TBuA+. The curves were obtained by fitting the Hill equation to the data. Mean ± S.D. values of Hill coefficients are indicated that were determined by fitting the Hill equation to individual experiments. ●P < 0.05; ●●P < 0.01, for difference to the Hill coefficient of wild-type rOCT1 determined by Student’s t test.

Fig. 6.
Fig. 6.

Inhibition of MPP+ uptake mediated by wild-type rOCT1 or rOCT1 mutants by extracellular TPeA+. (A) Effects of mutations of Phe160. (B) Effects of mutations of Trp218. (C) Effects of mutations of Tyr222, Thr226, and Arg440. (D) Effects of mutations of Leu447 and Asp475. In stably transfected HEK293 cells, initial uptake rates of 0.1 µM MPP+ traced with [3H]MPP+ were measured in the absence and presence of different concentrations of TPeA+. Mean ± S.D. values of three or four independent experiments are indicated. The measurements were performed, and the data were calculated and are presented as in Fig. 5. Student’s t tests: ●●●P < 0.001, for difference to the Hill coefficient of wild-type rOCT1, ▲▲▲P < 0.001, for difference to the Hill coefficient of mutant W218Y.

Fig. 7.
Fig. 7.

Inhibition of MPP+ uptake mediated by wild-type rOCT1 or rOCT1 mutants by extracellular corticosterone. (A) Effects of mutations of Phe160. (B) Effects of mutations of Trp218. (C) Effects of mutations of Tyr222, Thr226, and Arg440. (D) Effects of mutations of Leu447 and Asp475. In stably transfected HEK293 cells, initial uptake rates of 0.1 µM MPP+ traced with [3H]MPP+ were measured in the absence and presence of different concentrations of corticosterone. Mean ± S.D. values of three or four independent experiments are indicated. The measurements were performed, and the data were calculated and presented as in Fig. 5. ▲Mean value of Hill coefficient is more than 2× S.D. values below 1.

Results

Impact of Experimental Conditions on Affinities of rOCT1 for Substrates and Inhibitors and on Effects of Mutations on Affinities.

Largely different apparent Km values and IC50 values for substrates and inhibitors of OCT1 were determined in various laboratories using different expression systems and/or different experimental conditions for transport measurements (Koepsell et al., 2007; Nies et al., 2011). In different expression systems, such as X. laevis oocytes and epithelial cells, transporters may exist in diverging regulatory states. Using different incubation times for tracer uptake measurements may determine whether trans-zero cation import or net uptake of cation import minus cation export is analyzed. Tracer uptake in epithelial cells and cation-induced inward currents in voltage-clamped oocytes may record transport activity at different membrane potentials. When testing inhibitor affinities using different substrates, it turned out that the substrate properties may influence the IC50 values (Ahlin et al., 2011; Belzer et al., 2013; Thévenod et al., 2013). Previously, we characterized functional activities of wild-type rOCT1 and rOCT1 mutants expressed in oocytes of X. laevis by measuring tracer flux uptake after a 30-minute incubation at room temperature (Gorboulev et al., 1999; Popp et al., 2005) and by measuring cation-induced inward currents in voltage-clamped oocytes (Volk et al., 2009). We also measured the effects of a few mutations on initial rates of tracer flux at 37°C in stably transfected HEK293 cells (Egenberger et al., 2012). In other laboratories, functional analysis of hOCT1 was performed in stably transfected HEK293 cells by measuring tracer flux uptake in confluent cells using incubation times of several minutes duration (Nies et al., 2009; Chen et al., 2010; Tzvetkov et al., 2012; Matthaei et al., 2016).

In the present study, we compared apparent Km values and IC50 values of wild-type rOCT1 as well as variants rOCT1(Y222F) and rOCT1(D475E) in HEK293 cells and oocytes using different conditions for the uptake measurements. We measured apparent Km values for the uptake of TEA+ and MPP+, and IC50 values for inhibition of uptake of 0.1 µM MPP+ by TEA+ or TBuA+. Apparent Km values and IC50 values of wild-type rOCT1 and the two rOCT1 mutants are presented in Table 1, and the effects of the mutations on apparent Km values and IC50 values are shown in Fig. 1. Uptake was determined at 37°C in stably transfected HEK293 cells or at room temperature in oocytes. We analyzed initial uptake rates in dissociated HEK293 cells or uptake after a 2-minute incubation in confluent cell layers of HEK293 cells. For measurements of initial uptake rates, incubation times of 1 second [MPP+ uptake by wild-type rOCT1 and rOCT1(Y222F)], 5 seconds (MPP+ uptake by rOCT1(D475E)), and 10 seconds (TEA+ uptake) were used. In oocytes, the transporter was expressed by cRNA injection, and the uptake of radioactive MPP+ was measured after a 30-minute incubation.

For wild-type rOCT1, similar apparent Km values for TEA+ or MPP+ were determined in dissociated HEK293 cells and in oocytes, whereas the apparent Km values measured in confluent HEK293 cells were 5-fold to 6-fold (TEA+ uptake) or 16-fold to 20-fold (MPP+ uptake) higher (Table 1). The IC50 value for the inhibition of rOCT1-mediated uptake of 0.1 µM MPP+ by TEA+ measured in confluent HEK293 cells was 15 times higher than in dissociated HEK293 cells and 5 times higher than in oocytes (Table 1). For inhibition of rOCT1-mediated uptake of 0.1 µM MPP+ by TBuA+, an approximately eight times lower IC50 value was determined in dissociated HEK293 cells compared with confluent HEK293 cells or compared with oocytes (Table 1).

It is noteworthy that we observed that the experimental conditions used for uptake measurements also influenced the determined functional effects of the mutations. In mutant Y222F, the apparent Km value for TEA+ uptake measured in dissociated HEK293 cells was similar to that in wild-type rOCT1, whereas it was strongly decreased when uptake was measured in oocytes (Fig. 1A, left panel). Replacement of Asp475 by glutamate (mutant D475E) led to a similar strong decrease of the apparent Km value for TEA+ uptake determined in dissociated HEK293 cells and oocytes (Fig. 1A, left panel). The Y222F mutation did not alter the apparent Km value for MPP+ measured in dissociated or confluent HEK293 cells but induced an increase in apparent Km values in oocytes (Fig. 1A, right panel). In the D475E mutant, compared with wild-type the apparent Km value for MPP+ uptake was not changed in dissociated HEK293 cells whereas it was decreased by different degrees in confluent HEK293 cells and oocytes (Fig. 1A, right panel). In mutant Y222F, the IC50 value for the inhibition of MPP+ uptake by TEA+ was decreased compared with wild-type rOCT1 in dissociated HEK293 cells and oocytes, whereas it was not changed in confluent HEK293 cells (Fig. 1B, left panel). At variance, upon exchange of Asp475 with glutamate, the IC50 value for the inhibition of MPP+ uptake by TEA+ was not changed when analyzed in dissociated HEK293 cells, whereas it was strongly decreased when determined in confluent HEK293 cells and oocytes (Fig. 1B, right panel). Because of the Y222F mutation, the IC50 value for inhibition of MPP+ uptake by TBuA+ was decreased to different degrees in dissociated and confluent HEK293 cells but was not changed in oocytes (Fig. 1C, left panel). Upon replacement of Asp475 by glutamate, the IC50 value for the inhibition of MPP+ uptake by TBuA+ was halved in dissociated HEK293 cells and decreased by more than 90% in confluent HEK293 cells and oocytes (Fig. 1C, right panel).

Influence of the Substrate Concentration on the IC50 Values of Inhibitors.

Since rOCT1 contains high- and low-affinity cation binding sites (Gorbunov et al., 2008), we asked whether the inhibitors may inhibit cation transport with different affinities when different substrate concentrations far below their respective apparent Km value are used for uptake measurements. In HEK293 cells stably transfected with rOCT1, rOCT1(Y222F), or rOCT1(D475E), we therefore measured the inhibition of 1-second uptake [rOCT1, rOCT1(Y222F)] or 5-second uptake [rOCT1(D475E)] of 0.25 nM MPP+, 12.5 nM MPP+, or 0.1 µM MPP+ by various concentrations of TBuA+ and calculated the IC50 values by fitting the Hill equation to the data (Fig. 2; Table 2). Employing the three different MPP+ concentrations, three different IC50 values were obtained for rOCT1 and rOCT1(D475E), whereas the IC50 values determined for rOCT1(Y222F) were similar at all three MPP+ concentrations. Interestingly the IC50 values determined for rOCT1 and rOCT1(D475E) using 12.5 nM MPP+ were lower compared with the values determined with 0.1 µM MPP+ or 0.25 nM MPP+. Under most conditions a Hill coefficient around 1 was determined; however, Hill coefficients lower than 1 were obtained for inhibition of the uptake of 12.5 nM MPP+ by wild-type rOCT1 and for inhibition of the uptake of 0.25 nM MPP+ by rOCT1(D475E) (Fig. 2). Assuming that the effects of the different MPP+ concentrations (all of which are far below the apparent Km value of MPP+) are due to different interactions with high-affinity MPP+ binding sites, the data suggest that interactions with two high-affinity MPP+ binding sites are involved. The negative cooperativity observed under some conditions suggests that TBuA+ binds to two binding sites that interact under the respective conditions. Using different MPP+ concentrations for the uptake measurements, we also observed different effects of mutations on the efficacy of TBuA+ inhibition. The mutation Y222F decreased the IC50 value for TBuA+ inhibition of uptake of 0.1 µM MPP+ compared with wild-type rOCT1, but did not alter the IC50 value for TBuA+ inhibition of the uptake of 12.5 nM MPP+ or 0.25 nM MPP+ (Table 2). On the other hand, the mutation D475E decreased the IC50 value for TBuA+ inhibition of the uptake of 0.1 μM and 12.5 nM MPP+, but increased the IC50 for TBuA+ inhibition of the uptake of 0.25 nM MPP+.

Effects of Mutations in rOCT1 on Apparent Km Values for MPP+ and TEA+ Determined from Initial Uptake Rates in Transfected HEK293 Cells.

Measuring the inhibition of TEA+-induced currents by corticosterone in oocytes expressing rOCT1 mutants, we previously identified five amino acids (Phe160, Trp218, Arg440, Leu447, and Asp475) that are located in the outward-open cleft of our 3D structural model and influence the efficacy of corticosterone for the inhibition of TEA+ uptake (Volk et al., 2009). Performing 30-minute uptake measurements of TEA+ and MPP+ in oocytes expressing wild-type rOCT1 and mutants W218F and D475E, we observed that replacement of Asp475 by glutamate changed the apparent Km for TEA+ uptake whereas the replacement of Trp218 by phenylalanine did not alter the apparent Km values for TEA+ and MPP+ (Gorboulev et al., 1999; Popp et al., 2005). To study the functional significance of Phe160, Trp218, Arg440, Leu447, and Asp475 in the outward-facing cleft of our 3D structural model under optimal experimental conditions, we analyzed mutants F160A, F160Y, W218L, W218F, W218Y, R440K, L447F, L447Y, and D475E on trans-zero uniport transport activity by measuring the initial uptake rates of MPP+ and TEA+ in dissociated, stably transfected HEK293 cells. Replacements of Phe160 by tyrosine or alanine; of Trp218 by phenylalanine, tyrosine, or leucine; and of Leu447 by phenylalanine or tyrosine were performed to determine effects of slightly and distinctly different structural changes. We also investigated the effects of mutations Y222F and T226A because uptake measurements in oocytes revealed effects on apparent Km values for TEA+ and/or MPP+ by these mutations, although in our 3D structural models these amino acids were only found accessible in the inward-open cleft (Popp et al., 2005; Volk et al., 2009).

In HEK293 cells, the apparent Km value for MPP+ determined by fitting the Hill equation to the data was increased when Phe160 was exchanged by alanine or tyrosine, whereas the apparent Km value for TEA+ was not changed (Figs. 3A and 4A; Table 3). Although Hill coefficients at approximately 1 were determined for MPP+ uptake by wild-type rOCT1 and mutant F160A and for TEA+ uptake by wild-type rOCT1 and mutants F160A and F160Y, a negative cooperativity was obtained for MPP+ uptake by mutant F160Y (Figs. 3A and 4A). In HEK293 cells stably transfected with mutant W218Y, the apparent Km value for MPP+ uptake was strongly decreased compared with wild-type rOCT1 and a negative cooperativity was induced, whereas the apparent Km and Hill coefficient for TEA+ uptake remained unaltered (Figs. 3B and 4B; Table 3). When Trp218 was replaced by phenylalanine, the apparent Km value for MPP+ uptake and the Hill coefficient remained unchanged; however, the apparent Km value for TEA+ uptake was increased. In mutant W218L, no statistically significant TEA+ uptake could be detected, whereas the apparent Km for MPP+ uptake was increased. The apparent Km values for MPP+ and TEA+ uptake and the respective Hill coefficients were not altered when Tyr222 was replaced by phenylalanine (Figs. 3C and 4C; Table 3). In mutant T226A compared with wild-type, the apparent Km value for MPP+ uptake was increased and a negative cooperativity was induced, whereas the apparent Km value and Hill coefficient for TEA+ uptake remained unchanged (Figs. 3C and 4C; Table 3). In mutants R440K, L447F, L447Y, and D475E compared with wild-type, the apparent Km value for MPP+ uptake remained unchanged; however, a negative cooperativity was induced in D475E (Fig. 3, C and D; Table 3). The apparent Km value for TEA+ uptake compared with wild-type was decreased in mutants R440K and D475E, increased in mutant L447F, and unchanged in mutant L447Y. The respective Hill coefficient was increased in mutant R440K and not altered in mutants L447F, L447Y, and D475E (Fig. 4, C and D; Table 3). Considering that Phe160, Trp218, Arg440, Leu447, and Asp475 have been located in our 3D models to the outward- and inward-open binding cleft whereas Thr226 has been only assigned to the inward-open cleft (Popp et al., 2005; Volk et al., 2009), and assuming that extracellular substrate binding rather than intracellular substrate dissociation determines the apparent Km measured under trans-zero conditions (see Discussion), the data may be interpreted as follows: the effects of the mutations of Trp218 on apparent Km values for MPP+ and TEA+ uptake suggest that Trp218 interacts directly with both substrates in the outward-open cleft. Direct interaction of MPP+ with Phe160 in the outward-open cleft is also suggested by the effects of mutations on the apparent Km values for MPP+ uptake, whereas direct interactions of TEA+ with Arg440, Leu447, and Asp475 are suggested by altered Km values observed for TEA+ uptake. The Hill coefficients different from 1 observed for MPP+ uptake in mutants F160Y, W218Y, and D475E suggest the existence of two transport-relevant binding sites for MPP+ in which cooperative interactions are induced by the respective mutations. The effect of the mutation of Thr226 on the Km for MPP+ uptake may be due to an allosteric effect on substrate binding to the outward-open cleft.

Different Effects of Mutations in rOCT1 on IC50 Values for Inhibition of MPP+ Uptake by TEA+ Versus Apparent Km Values of TEA+ Uptake.

Measurements with rOCT1, rOCT1(Y222F), and rOCT1(D475E) presented in Table 1 indicate that under identical experimental conditions partially different values were determined for the apparent Km value of TEA+ uptake versus the respective IC50 value for the inhibition of 0.1 µM MPP+ uptake by TEA+. In some cases, different effects of mutagenesis on the apparent Km value versus the respective IC50 value were observed. These data indicate complex interactions between MPP+ and TEA+ that are influenced by single point mutations. To evaluate the impact of all investigated mutations on these interactions between MPP+ and TEA+, we also measured the IC50 values for inhibition of the uptake of 0.1 µM MPP+ by TEA+ after mutation of Phe160, Trp218, Thr226, Arg440, or Leu447. The data obtained for wild-type rOCT1 and all investigated mutants are shown in Supplemental Fig. 4. In Supplemental Table 1, a comparison between the IC50 values for TEA+ inhibition of MPP+ uptake and the apparent Km values for TEA+ uptake is presented. In wild-type rOCT1, the IC50 value is 37% smaller than the apparent Km value. For mutants F160A, W218F, W218Y, R440K, and L447Y, similar IC50 and apparent Km values were determined, whereas 2.7-fold to 3.8-fold diverging IC50 and apparent Km values were obtained for mutants F160Y, Y222F, T226A, L447F, and D475E. In consequence, these mutations induced different effects on the IC50 and apparent Km values. Whereas for the inhibition of MPP+ uptake by TEA+ in wild-type rOCT1 and most mutants a Hill coefficient of approximately 1 one was determined, positive cooperativity was observed for mutant F160Y and negative cooperativity was observed for mutants W218L, T226A, and L447F (Supplemental Fig. 4). The observations suggest the effects of mutations of Phe160, Tyr222, Thr226, Leu447, and Asp475 on simultaneous binding of TEA+ and MPP+, which allow mutual direct and/or allosteric interactions between the two substrates.

Effects of Mutations in rOCT1 on IC50 Values for Inhibition of MPP+ Uptake by Nontransported Inhibitors.

Next, we determined whether the above-mentioned mutations in rOCT1 influence the inhibition of 1- or 5-second uptake of 0.1 µM MPP+ by TBuA+, TPeA+, and corticosterone (Figs. 5–7; Table 4). Since these inhibitors are not transported by rOCT1 (Nagel et al., 1997; Gorboulev et al., 1999, 2005; Koepsell et al., 2007; Volk et al., 2009) and passive diffusion during 1- or 5-second incubation can be neglected, the inhibition must be due to binding of the inhibitors to the outward-open cleft of rOCT1. MPP+ uptake mediated by wild-type rOCT1 was reduced >90% by 50 µM TBuA+ (Fig. 5), >95% by 10 µM TPeA+ (Fig. 6), and >95% by 200 µM corticosterone (Fig. 7). With one exception (inhibition of the mutant W218L by TPeA+) (Fig. 6B), the obtained inhibition curves suggest that the mutations do not diminish maximal inhibition. However, several mutations alter the affinities of the inhibitors for rOCT1, as indicated by altered IC50 values (Table 4). The IC50 values of TBuA+, TPeA+, and corticosterone were decreased when Asp475 was replaced by glutamate and altered after the replacement of Trp218 by phenylalanine, tyrosine, and/or leucine. Different effects of the mutations were observed for different inhibitors. For example, in mutant W218F the IC50 value for TBuA+ was increased 5.3-fold, the IC50 value for TPeA+ was decreased 9-fold, and the IC50 value for corticosterone was increased 2.7-fold. Notably, largely different IC50 values were obtained when Trp218 was replaced by tyrosine versus phenylalanine, although the replaced amino acids only differ by one hydroxyl group. In mutant W218Y, the IC50 for TBuA+ was 10.6 times lower than in W218F, whereas the IC50 values for TPeA+ and corticosterone were increased 6.7-fold and 3.3-fold, respectively. Upon exchange of Phe160 by alanine, the IC50 values for TBuA+ and corticosterone were decreased 2.3-fold and 2.9-fold, respectively, whereas the IC50 value for TPeA+ was not changed. The conservative exchange of Phe160 by tyrosine only altered the IC50 value for TBuA+, a 10-fold increased concentration was required for half-maximal inhibition. In the mutant T226A, the IC50 values for TBuA+ and corticosterone were increased 6.5-fold and 3-fold, respectively, whereas in the variant L447Y the IC50 values for TPeA+ and corticosterone were increased 1.8-fold and 3-fold, respectively.

View this table:
TABLE 4

Inhibition of MPP+ uptake via rOCT1 wild-type (WT) and rOCT1 mutants by three nontransported inhibitors

Uptake measurements were performed at 37°C in stably transfected HEK293 cells using an incubation time of 1 s, except in mutant D475E where a 5-s incubation was performed. Uptake of 0.1 [3H]MPP+ was measured in the presence of different concentrations of TBuA+, TPeA+, and corticosterone. Mean ± S.D. values of three to five separate experiments are shown. The compiled uptake measurements and the calculated Hill coefficients are shown in Figs. 5–7.

For inhibition of wild-type rOCT1 and most rOCT1 mutants by TBuA+, TPeA+, or corticosterone, Hill coefficients at approximately 1 were observed (Figs. 5–7). However, for the inhibition of MPP+ uptake by TBuA+, negative cooperativity was induced after replacement of Phe160 by tyrosine, after replacement of Trp218 by phenylalanine, and after replacement of Tyr222 by phenylalanine (Fig. 5). For the inhibition of MPP+ uptake by TPeA+, negative cooperativity was induced when Trp218 was replaced by phenylalanine (Fig. 6), whereas for inhibition of MPP+ uptake by corticosterone negative cooperativity was observed in mutants F160Y, W218F, and L447F (Fig. 7).

The data suggest that Asp475 and Trp218 are directly involved in the binding of TBuA+, TPeA+, and corticosterone to the outward-open cleft, that Leu447 participates in binding of TPeA and corticosterone to the outward-open cleft, and that Phe160 is directly involved in the binding of TBuA+ from the extracellular side. The observation of cooperativity for the inhibition of MPP+ uptake by TBuA+, TPeA+, and corticosterone in some mutants suggests that rOCT1 contains more than one extracellular binding sites for each of these inhibitors. Because Thr226 has been found to be accessible at the inward-open but not at the outward-open cleft of our 3D structural models of rOCT1, the exchange of Thr226 by alanine in this position probably exhibits an allosteric effect on the extracellular binding sites of TBuA+ and corticosterone.

Re-evaluation of Previous Model-Predicted Locations of the Phe160, Trp218, Arg440, and Asp475 within the Outward-Open Cleft of rOCT1 Using a New Model of hOCT1.

The mechanisms proposed to explain the observed effects of the analyzed mutations depend largely on the assigned locations of the respective residues in the outward-open cleft and hence depend on the quality of the outward-facing 3D homology rOCT1 model (Gorbunov et al., 2008; Volk et al., 2009). Our outward-facing 3D model was built manually on the basis of a 3D homology rOCT1 model in the inward-facing conformation that was modeled from the crystal structure of lactose permease (Abramson et al., 2003; Popp et al., 2005). To obtain the outward-open conformation, we assumed (and used) a rigid-body movement of the first (N-terminal) six helices with respect to the last (C-terminal) six helices, which transformed the inward-open confirmation into an outward-open conformation. Minor manual rebuilding allowing for some intrahelical motions and drifting of individual domains was necessary to remove van der Waals clashes. A very similar helix rearrangement has been proposed, modeled, and also experimentally verified for lactose permease (Ermolova et al., 2006; Holyoake and Sansom, 2007; Kaback et al., 2007). Recently, an outward-facing partially closed structure of hOCT1 was modeled using crystal structures of various transporters from the MFS superfamily as templates (Dakal et al., 2017). With the exception of Leu447 (with isoleucine in the corresponding position of hOCT1), the amino acids of rOCT1 investigated in this article are conserved in hOCT1 (Supplemental Fig. 5). The positions of the amino acids mutated in our study that were assigned to the outward-facing cleft are highly similar between our rOCT1 3D model and the novel 3D model of hOCT1 in an outward-facing conformation (Supplemental Fig. 6). Both models predict that Phe160, Trp218 (Trp217), Arg440 (Arg439), Leu447 (Ile446). and Asp475 (Asp474) are located within the extracellular cleft and presumably are accessible from the extracellular side. In Fig. 8, views from the extracellular space into the outward-facing cleft of our 3D rOCT1 model are presented and the mutated amino acids, which are accessible from the extracellular space, are indicated. In the model, Phe160, Trp218, Arg440, Leu447, and Asp475 are surface accessible in the outward-open cleft. Trp218 and Asp475 are located in close proximity with Phe160 and Leu447 in nearby positions. In contrast, Arg440 is located at some distance on the opposite side of the cleft.

Fig. 8.
Fig. 8.

Views from the extracellular side on the 3D structural model of the outward-facing conformation or rOCT1 with indicated positions of Phe160, Trp218, Arg440, Leu447, and Asp475. (A) Secondary structure cartoon in which the 12 transmembrane helices are shown as solid tubes and numbered accordingly. The residues are shown as sticks, with Phe160 shown in magenta, Trp218 shown in green, Arg440 shown in blue, Leu 447 shown in yellow, and Asp475 shown in red. (B) Surface representation of (A) using the same color coding. (C) Surface representations of the outward-facing conformation of rOCT1 viewed from different angles in which the surface representation of Phe160 or Leu447 becomes visible. Trp218 and Asp475 with nearby Phe160 and Leu447 form one surface patch. Arg440 in a distant location is also well accessible to the surface.

Discussion

We report that the experimental conditions used for studying the transport and inhibition of rOCT1 can have dramatic impact on the effects of mutations on affinities. The data are relevant for in vitro characterization of drug interactions with OCTs and OCT mutants and for molecular interpretation of mutagenesis experiments. Measuring initial uptake rates under trans-zero conditions in stably transfected HEK293 cells, we identified the interactions of inhibitors and determined the probable interactions of substrates with five amino acids in the outward-open cleft of rOCT1. Trp218 and Asp475 most likely interact with the nontransported inhibitors TBuA+, TPeA+, and corticosterone, and presumably also with one or two substrates (Asp475 with TEA, and Trp218 with MPP+ and TEA+). Phe160 most likely interacts with TBuA+ and corticosterone, and probably also with MPP+, whereas Leu447 most likely interacts with TPeA+, and probably also with TEA+. Arg440 probably interacts with TEA+. Fitting the Hill equation to data describing the concentration dependence of MPP+ uptake, Hill coefficients smaller than one were determined for four mutants. This suggests the existence of two transport-relevant, low-affinity MPP+ binding sites that exhibit negative cooperativity in the respective mutants. Recent experiments support this interpretation (unpublished data). Measuring MPP+ binding to rOCT1 and rOCT1 mutants, which were reconstituted into lipid nanodiscs (Bayburt and Sligar, 2002), and measuring MPP+ uptake into proteoliposomes containing rOCT1 and rOCT1 mutants, we observed that rOCT1 contains two low-affinity, transport-relevant MPP+ binding sites per rOCT1 monomer that have similar dissociation constants and are located in the modeled outward-facing cleft of rOCT1.

Our interpretations concerning the interactions of the inhibitors or substrates with amino acids in the outward-open cleft are based on two or three presumptions, respectively. First, it is presumed that Phe160, Trp218, Leu447, Arg440, and Asp475 are located at the inner surface of the outward-facing cleft of rOCT1 as predicted by modeling (see Fig. 8). The second presumption is that the changes in affinities observed in the mutants reflect direct effects on the binding of the substrates and/or inhibitors to the respective amino acids. Our interpretation concerning the interaction of the substrates is additionally based on the presumption that the determined apparent Km values measuring initial uptake rates reflect the binding affinities of these compounds to the extracellular-facing cleft.

Due to the limited sequence homology of rOCT1 and hOCT1 to their structure templates and the fact that the conformational variability of the transporters is not known, the predictive potential of the models is inherently limited. However, considering that the models of rOCT1 and hOCT1 were derived from rather different modeling techniques and are based on quite different structure templates, the finding of highly similar positions for the five amino acid residues in the outward-facing clefts might serve as an indication that these models come close to the real OCT1 structure and our first presumption is justified (see Supplemental Fig. 6).

Although a potential involvement of allosteric effects on the binding of inhibitors is indicated by the observation of affinity changes of nontransported inhibitors upon mutation of Thr226, which is not accessible from the extracellular side (Supplemental Fig. 6; Table 4), it is more likely that the nontransported inhibitors directly interact with Phe160, Trp218, Arg440, Leu447, and Asp475. Thus, according to our model these amino acids are located at the surface of the outward-open cleft (Fig. 8; Supplemental Fig. 6), and mutating these amino acids affects both the IC50 values for nontransported inhibitors and the apparent Km values of substrates (Tables 3 and 4). In addition, the exchange of Phe160, Trp218, and Leu447 for different amino acids alters the affinities of structurally diverse nontransported inhibitors in different ways (Table 4).

The third presumption that the Km values reflect the affinities of MPP+ and TEA+ binding to the outward-facing cleft, probably matches reality, because we measured initial uptake rates, and OCT1 operates as a cellular uptake system, which is supposed to have a higher affinity for extracellular substrate binding compared with intracellular substrate dissociation (Koepsell, 2011).

We showed that the experimental conditions used for in vitro uptake measurements in transfected HEK293 cells have dramatic effects on the affinities of substrates and inhibitors. Not only were the apparent Km values of rOCT1-mediated cation transport and the IC50 values for the inhibition of transport different, but so also were the effects of mutations on apparent Km values and IC50 values when uptake was measured in dissociated HEK293 cells using 1-, 5-, or 10-second incubation times compared with uptake measurements performed with confluent HEK293 cells using a 2-minute incubation time. The differences may be due to differing regulatory states of OCT1 in dissociated versus confluent cells, to different impacts of unstirred layer effects, and/or to the assessment of different transport modes. When dissociated HEK293 cells expressing rOCT1 or hOCT1 were incubated for 1–3 seconds with radioactively labeled MPP+ while performing vigorous shaking, initial linear uptake rates were determined that are higher compared with the uptake rates observed later on (Busch et al., 1996a; Minuesa et al., 2009). These initial uptake rates represent a uniport transport mode involving extracellular substrate binding, substrate translocation, intracellular substrate dissociation, and reorientation of the empty transporter (Koepsell 2011). In performing a 2-minute incubation, the transport mode may change during incubation because of an increase of intracellular substrate. This may lead to transporter-mediated efflux of radioactive substrate resulting in a slowed-down net uptake of radioactivity. It is noteworthy that the apparent linearity of radioactive uptake, which has been reported for cell layers using incubation times between 30–60 seconds and 2–5 minutes (Bednarczyk et al., 2003; Cheng et al., 2011; Chen et al., 2017), did not exclude higher uptake rates within the first seconds. Measuring the uptake of 0.1 µM radioactively labeled MPP+ in monolayers of HEK293 cells stably transfected with rOCT1 or hOCT1 between incubation times of 30 seconds and 10 minutes, we observed a relatively high cell-associated MPP+ concentration at 30 seconds that is most probably due to a rapid initial uptake rate (Busch et al., 1996a; Minuesa et al., 2009) and a much slower linear uptake between 30 seconds and 2 minutes (Supplemental Fig. 7). Because mutations may change cation import and cation export differently and because net uptake of radioactive substrate observed after a 2-minute incubation probably reflects the difference between uptake and efflux of the radioactive substrate, it is difficult to explain the functional effects of mutations observed after a 2-minute incubation on the molecular level.

Recently, we observed that the uptake of MPP+ in HEK293 cells stably transfected with hOCT1 was inhibited with different affinities by pentamidine when MPP+ was applied at different concentrations far below the apparent Km value for MPP+ (Minuesa et al., 2017). This indicates that the affinity of inhibitors is not only influenced by the molecular structure of the transported drug as described previously (Belzer et al., 2013; Thévenod et al., 2013), but also by the concentration of the substrate. In the present study, we showed also for rOCT1 that the inhibitor sensitivity is dependent on the substrate concentration. Furthermore, we demonstrated that the substrate concentration also influences the effects of mutations on inhibitor sensitivity. We determined different IC50 values for the inhibition of rOCT1-mediated MPP+ uptake by TBuA+ using different nanomolar concentrations of MPP+ and showed that the influence of nanomolar MPP+ concentrations on the IC50 value for TBuA+ was altered differently in different OCT1 mutants. The most probable explanation for these properties of the transporter is that differing occupation of high-affinity substrate binding sites induces different allosteric effects on the transport-relevant cation binding sites and that mutations within the transport-relevant sites modulate this allosteric response.

The dramatic impact of experimental conditions on the measured affinities of substrates and inhibitors should be considered for further investigation of the structure-function relationship by mutagenesis, and for in vitro analysis of how polymorphisms influence drug affinities and drug-drug interactions at hOCT1 or the other OCT subtypes (Koepsell, 2015). To characterize the molecular impact of individual amino acids on binding or transport in mutagenesis studies defined transport modes should be analyzed. For example, initial trans-zero uptake may be determined as performed in the present study using short-term incubation of dissociated cells including rigorous shaking to minimize unstirred layer effects. For in vitro characterization of the effects of polymorphisms in hOCT1, human OCT2, or human OCT3 on drug transport or for in vitro characterizations of drug-drug interactions, conditions should be used that reflect the in vivo exposition with organic cations. Hence in vivo transport measured with relatively long incubation times or under equilibrium conditions is more relevant than initial uptake. Measuring the inhibition of OCT-mediated drug transport by a second drug, drug concentrations within the ranges of their free blood concentrations should be used and the tests should be extended to frequently occurring polymorphisms in the respective transporter (Koepsell, 2015).

Acknowledgments

The authors thank Irina Schatz and Alla Ganscher from the Institute of Anatomy and Cell Biology of the University of Würzburg (Germany) for expert technical assistance and Michael Christof from the Institute of Anatomy and Cell Biology of the University of Würzburg for generating the figures.

Authorship Contributions

Participated in research design: Koepsell.

Conducted experiments: Gorboulev, Rehman, Albert, Roth, Meyer, Tzvetkov, Mueller.

Performed data analysis: Rehman, Albert, Roth, Meyer, Tzvetkov, Mueller, Koepsell.

Wrote or contributed to the writing of the manuscript: Koepsell.

Footnotes

Abbreviations

3D
three-dimensional
ANOVA
analysis of variance
cRNA
complementary RNA
HEK
human embryonic kidney
hOCT
human organic cation transporter
Km
Michaelis-Menten constant
MFS
major facilitator superfamily
Mg-Ca-PBS
0.5 mM MgCl2 and 1 mM CaCl2
MOPS
4-morpholinepropanesulfonic acid
MPP+
1-methyl-4-phenylpyridinium+
OCT
organic cation transporter
PBS
phosphate-buffered saline
rOCT
rat organic cation transporter
TBuA+
tetrabutylammonium+
TEA+
tetraethylammonium+
TPeA+
tetrapentylammonium+

References

  1. ↵
    1. Abramson J,
    2. Smirnova I,
    3. Kasho V,
    4. Verner G,
    5. Kaback HR, and
    6. Iwata S
    (2003) Structure and mechanism of the lactose permease of Escherichia coli. Science 301:610–615.
    OpenUrlAbstract/FREE Full Text
  2. ↵
    1. Ahlin G,
    2. Chen L,
    3. Lazorova L,
    4. Chen Y,
    5. Ianculescu AG,
    6. Davis RL,
    7. Giacomini KM, and
    8. Artursson P
    (2011) Genotype-dependent effects of inhibitors of the organic cation transporter, OCT1: predictions of metformin interactions. Pharmacogenomics J 11:400–411.
    OpenUrlCrossRefPubMed
  3. ↵
    1. Ahlin G,
    2. Karlsson J,
    3. Pedersen JM,
    4. Gustavsson L,
    5. Larsson R,
    6. Matsson P,
    7. Norinder U,
    8. Bergström CA, and
    9. Artursson P
    (2008) Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1. J Med Chem 51:5932–5942.
    OpenUrlCrossRefPubMed
  4. ↵
    1. Arndt P,
    2. Gorboulev V,
    3. Nagel G,
    4. Friedrich T,
    5. Gambaryan S,
    6. Volk C, and
    7. Koepsell H
    (1998) Functional properties of the polyspecific rat organic cation transporter rOCT2. Nova Acta Leopoldina NF 78 306:347–348.
    OpenUrl
  5. ↵
    1. Arndt P,
    2. Volk C,
    3. Gorboulev V,
    4. Budiman T,
    5. Popp C,
    6. Ulzheimer-Teuber I,
    7. Akhoundova A,
    8. Koppatz S,
    9. Bamberg E,
    10. Nagel G, et al.
    (2001) Interaction of cations, anions, and weak base quinine with rat renal cation transporter rOCT2 compared with rOCT1. Am J Physiol Renal Physiol 281:F454–F468.
    OpenUrlPubMed
  6. ↵
    1. Bayburt TH and
    2. Sligar SG
    (2002) Single-molecule height measurements on microsomal cytochrome P450 in nanometer-scale phospholipid bilayer disks. Proc Natl Acad Sci USA 99:6725–6730.
    OpenUrlAbstract/FREE Full Text
  7. ↵
    1. Bednarczyk D,
    2. Ekins S,
    3. Wikel JH, and
    4. Wright SH
    (2003) Influence of molecular structure on substrate binding to the human organic cation transporter, hOCT1. Mol Pharmacol 63:489–498.
    OpenUrlAbstract/FREE Full Text
  8. ↵
    1. Belzer M,
    2. Morales M,
    3. Jagadish B,
    4. Mash EA, and
    5. Wright SH
    (2013) Substrate-dependent ligand inhibition of the human organic cation transporter OCT2. J Pharmacol Exp Ther 346:300–310.
    OpenUrlAbstract/FREE Full Text
  9. ↵
    1. Budiman T,
    2. Bamberg E,
    3. Koepsell H, and
    4. Nagel G
    (2000) Mechanism of electrogenic cation transport by the cloned organic cation transporter 2 from rat. J Biol Chem 275:29413–29420.
    OpenUrlAbstract/FREE Full Text
  10. ↵
    1. Busch AE,
    2. Quester S,
    3. Ulzheimer JC,
    4. Gorboulev V,
    5. Akhoundova A,
    6. Waldegger S,
    7. Lang F, and
    8. Koepsell H
    (1996a) Monoamine neurotransmitter transport mediated by the polyspecific cation transporter rOCT1. FEBS Lett 395:153–156.
    OpenUrlCrossRefPubMed
  11. ↵
    1. Busch AE,
    2. Quester S,
    3. Ulzheimer JC,
    4. Waldegger S,
    5. Gorboulev V,
    6. Arndt P,
    7. Lang F, and
    8. Koepsell H
    (1996b) Electrogenic properties and substrate specificity of the polyspecific rat cation transporter rOCT1. J Biol Chem 271:32599–32604.
    OpenUrlAbstract/FREE Full Text
  12. ↵
    1. Chen EC,
    2. Khuri N,
    3. Liang X,
    4. Stecula A,
    5. Chien HC,
    6. Yee SW,
    7. Huang Y,
    8. Sali A, and
    9. Giacomini KM
    (2017) Discovery of competitive and noncompetitive ligands of the organic cation transporter 1 (OCT1; SLC22A1). J Med Chem 60:2685–2696.
    OpenUrl
  13. ↵
    1. Chen L,
    2. Takizawa M,
    3. Chen E,
    4. Schlessinger A,
    5. Segenthelar J,
    6. Choi JH,
    7. Sali A,
    8. Kubo M,
    9. Nakamura S,
    10. Iwamoto Y, et al.
    (2010) Genetic polymorphisms in organic cation transporter 1 (OCT1) in Chinese and Japanese populations exhibit altered function. J Pharmacol Exp Ther 335:42–50.
    OpenUrlAbstract/FREE Full Text
  14. ↵
    1. Cheng Y,
    2. Martinez-Guerrero LJ,
    3. Wright SH,
    4. Kuester RK,
    5. Hooth MJ, and
    6. Sipes IG
    (2011) Characterization of the inhibitory effects of N-butylpyridinium chloride and structurally related ionic liquids on organic cation transporters 1/2 and human toxic extrusion transporters 1/2-k in vitro and in vivo. Drug Metab Dispos 39:1755–1761.
    OpenUrlAbstract/FREE Full Text
  15. ↵
    1. Dakal TC,
    2. Kumar R, and
    3. Ramotar D
    (2017) Structural modeling of human organic cation transporters. Comput Biol Chem 68:153–163.
    OpenUrl
  16. ↵
    1. Egenberger B,
    2. Gorboulev V,
    3. Keller T,
    4. Gorbunov D,
    5. Gottlieb N,
    6. Geiger D,
    7. Mueller TD, and
    8. Koepsell H
    (2012) A substrate binding hinge domain is critical for transport-related structural changes of organic cation transporter 1. J Biol Chem 287:31561–31573.
    OpenUrlAbstract/FREE Full Text
  17. ↵
    1. Ermolova N,
    2. Madhvani RV, and
    3. Kaback HR
    (2006) Site-directed alkylation of cysteine replacements in the lactose permease of Escherichia coli: helices I, III, VI, and XI. Biochemistry 45:4182–4189.
    OpenUrlCrossRefPubMed
  18. ↵
    1. Gorboulev V,
    2. Shatskaya N,
    3. Volk C, and
    4. Koepsell H
    (2005) Subtype-specific affinity for corticosterone of rat organic cation transporters rOCT1 and rOCT2 depends on three amino acids within the substrate binding region. Mol Pharmacol 67:1612–1619.
    OpenUrlAbstract/FREE Full Text
  19. ↵
    1. Gorboulev V,
    2. Volk C,
    3. Arndt P,
    4. Akhoundova A, and
    5. Koepsell H
    (1999) Selectivity of the polyspecific cation transporter rOCT1 is changed by mutation of aspartate 475 to glutamate. Mol Pharmacol 56:1254–1261.
    OpenUrlAbstract/FREE Full Text
  20. ↵
    1. Gorbunov D,
    2. Gorboulev V,
    3. Shatskaya N,
    4. Mueller T,
    5. Bamberg E,
    6. Friedrich T, and
    7. Koepsell H
    (2008) High-affinity cation binding to organic cation transporter 1 induces movement of helix 11 and blocks transport after mutations in a modeled interaction domain between two helices. Mol Pharmacol 73:50–61.
    OpenUrlAbstract/FREE Full Text
  21. ↵
    1. Gründemann D,
    2. Gorboulev V,
    3. Gambaryan S,
    4. Veyhl M, and
    5. Koepsell H
    (1994) Drug excretion mediated by a new prototype of polyspecific transporter. Nature 372:549–552.
    OpenUrlCrossRefPubMed
  22. ↵
    1. Gründemann D and
    2. Koepsell H
    (1994) Ethidium bromide staining during denaturation with glyoxal for sensitive detection of RNA in agarose gel electrophoresis. Anal Biochem 216:459–461.
    OpenUrlCrossRefPubMed
  23. ↵
    1. Ho SN,
    2. Hunt HD,
    3. Horton RM,
    4. Pullen JK, and
    5. Pease LR
    (1989) Site-directed mutagenesis by overlap extension using the polymerase chain reaction. Gene 77:51–59.
    OpenUrlCrossRefPubMed
  24. ↵
    1. Holyoake J and
    2. Sansom MSP
    (2007) Conformational change in an MFS protein: MD simulations of LacY. Structure 15:873–884.
    OpenUrlCrossRefPubMed
  25. ↵
    1. Kaback HR,
    2. Dunten R,
    3. Frillingos S,
    4. Venkatesan P,
    5. Kwaw I,
    6. Zhang W, and
    7. Ermolova N
    (2007) Site-directed alkylation and the alternating access model for LacY. Proc Natl Acad Sci USA 104:491–494.
    OpenUrlAbstract/FREE Full Text
  26. ↵
    1. Koepsell H
    (2011) Substrate recognition and translocation by polyspecific organic cation transporters. Biol Chem 392:95–101.
    OpenUrlCrossRefPubMed
  27. ↵
    1. Koepsell H
    (2013) The SLC22 family with transporters of organic cations, anions and zwitterions. Mol Aspects Med 34:413–435.
    OpenUrlCrossRefPubMed
  28. ↵
    1. Koepsell H
    (2015) Role of organic cation transporters in drug-drug interaction. Expert Opin Drug Metab Toxicol 11:1619–1633.
    OpenUrl
  29. ↵
    1. Koepsell H,
    2. Lips K, and
    3. Volk C
    (2007) Polyspecific organic cation transporters: structure, function, physiological roles, and biopharmaceutical implications. Pharm Res 24:1227–1251.
    OpenUrlCrossRefPubMed
  30. ↵
    1. Lin L,
    2. Yee SW,
    3. Kim RB, and
    4. Giacomini KM
    (2015) SLC transporters as therapeutic targets: emerging opportunities. Nat Rev Drug Discov 14:543–560.
    OpenUrl
  31. ↵
    1. Matthaei J,
    2. Kuron D,
    3. Faltraco F,
    4. Knoch T,
    5. Dos Santos Pereira JN,
    6. Abu Abed M,
    7. Prukop T,
    8. Brockmöller J, and
    9. Tzvetkov MV
    (2016) OCT1 mediates hepatic uptake of sumatriptan and loss-of-function OCT1 polymorphisms affect sumatriptan pharmacokinetics. Clin Pharmacol Ther 99:633–641.
    OpenUrl
  32. ↵
    1. Minuesa G,
    2. Albert C,
    3. Pastor-Anglada M,
    4. Martinez-Picado J, and
    5. Koepsell H
    (2017) Response to “Tenofovir disoproxil fumarate is not an inhibitor of human organic cation transporter 1”. J Pharmacol Exp Ther 360:343–345.
    OpenUrlFREE Full Text
  33. ↵
    1. Minuesa G,
    2. Volk C,
    3. Molina-Arcas M,
    4. Gorboulev V,
    5. Erkizia I,
    6. Arndt P,
    7. Clotet B,
    8. Pastor-Anglada M,
    9. Koepsell H, and
    10. Martinez-Picado J
    (2009) Transport of lamivudine [(-)-beta-L-2′,3′-dideoxy-3′-thiacytidine] and high-affinity interaction of nucleoside reverse transcriptase inhibitors with human organic cation transporters 1, 2, and 3. J Pharmacol Exp Ther 329:252–261.
    OpenUrlAbstract/FREE Full Text
  34. ↵
    1. Nagel G,
    2. Volk C,
    3. Friedrich T,
    4. Ulzheimer JC,
    5. Bamberg E, and
    6. Koepsell H
    (1997) A reevaluation of substrate specificity of the rat cation transporter rOCT1. J Biol Chem 272:31953–31956.
    OpenUrlAbstract/FREE Full Text
  35. ↵
    1. Nies AT,
    2. Koepsell H,
    3. Damme K, and
    4. Schwab M
    (2011) Organic cation transporters (OCTs, MATEs), in vitro and in vivo evidence for the importance in drug therapy. Handb Exp Pharmacol 201:105–167.
    OpenUrlCrossRefPubMed
  36. ↵
    1. Nies AT,
    2. Koepsell H,
    3. Winter S,
    4. Burk O,
    5. Klein K,
    6. Kerb R,
    7. Zanger UM,
    8. Keppler D,
    9. Schwab M, and
    10. Schaeffeler E
    (2009) Expression of organic cation transporters OCT1 (SLC22A1) and OCT3 (SLC22A3) is affected by genetic factors and cholestasis in human liver. Hepatology 50:1227–1240.
    OpenUrlCrossRefPubMed
  37. ↵
    1. Pao SS,
    2. Paulsen IT, and
    3. Saier MH Jr.
    (1998) Major facilitator superfamily. Microbiol Mol Biol Rev 62:1–34.
    OpenUrlAbstract/FREE Full Text
  38. ↵
    1. Popp C,
    2. Gorboulev V,
    3. Müller TD,
    4. Gorbunov D,
    5. Shatskaya N, and
    6. Koepsell H
    (2005) Amino acids critical for substrate affinity of rat organic cation transporter 1 line the substrate binding region in a model derived from the tertiary structure of lactose permease. Mol Pharmacol 67:1600–1611.
    OpenUrlAbstract/FREE Full Text
  39. ↵
    1. Thévenod F,
    2. Ciarimboli G,
    3. Leistner M,
    4. Wolff NA,
    5. Lee WK,
    6. Schatz I,
    7. Keller T,
    8. Al-Monajjed R,
    9. Gorboulev V, and
    10. Koepsell H
    (2013) Substrate- and cell contact-dependent inhibitor affinity of human organic cation transporter 2: studies with two classical organic cation substrates and the novel substrate cd2+. Mol Pharm 10:3045–3056.
    OpenUrlCrossRef
  40. ↵
    1. Tzvetkov MV,
    2. Saadatmand AR,
    3. Bokelmann K,
    4. Meineke I,
    5. Kaiser R, and
    6. Brockmöller J
    (2012) Effects of OCT1 polymorphisms on the cellular uptake, plasma concentrations and efficacy of the 5-HT(3) antagonists tropisetron and ondansetron. Pharmacogenomics J 12:22–29.
    OpenUrlCrossRefPubMed
  41. ↵
    1. Volk C,
    2. Gorboulev V,
    3. Budiman T,
    4. Nagel G, and
    5. Koepsell H
    (2003) Different affinities of inhibitors to the outwardly and inwardly directed substrate binding site of organic cation transporter 2. Mol Pharmacol 64:1037–1047.
    OpenUrlAbstract/FREE Full Text
  42. ↵
    1. Volk C,
    2. Gorboulev V,
    3. Kotzsch A,
    4. Müller TD, and
    5. Koepsell H
    (2009) Five amino acids in the innermost cavity of the substrate binding cleft of organic cation transporter 1 interact with extracellular and intracellular corticosterone. Mol Pharmacol 76:275–289.
    OpenUrlAbstract/FREE Full Text
View Abstract
Back to top

In this issue

Download PDF
Article Alerts
Email Article
Citation Tools
Research ArticleArticle

Three Extracellular Inhibitors Bind to Amino Acids in OCT1

Valentin Gorboulev, Saba Rehman, Christoph M. Albert, Ursula Roth, Marleen J. Meyer, Mladen V. Tzvetkov, Thomas D. Mueller and Hermann Koepsell
Molecular Pharmacology April 1, 2018, 93 (4) 402-415; DOI: https://doi.org/10.1124/mol.117.110767
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo

Jump to section